ATE28477T1 - Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen. - Google Patents
Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen.Info
- Publication number
- ATE28477T1 ATE28477T1 AT85400080T AT85400080T ATE28477T1 AT E28477 T1 ATE28477 T1 AT E28477T1 AT 85400080 T AT85400080 T AT 85400080T AT 85400080 T AT85400080 T AT 85400080T AT E28477 T1 ATE28477 T1 AT E28477T1
- Authority
- AT
- Austria
- Prior art keywords
- muramylpeptide
- combined
- hapten
- antigen
- muramylpeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8400676A FR2558165B1 (fr) | 1984-01-17 | 1984-01-17 | Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages |
| EP85400080A EP0149581B1 (de) | 1984-01-17 | 1985-01-17 | Oligo-Muramylpeptide enthaltende Zubereitungen und ihre Verwendung, insbesondere für die Aktivierung von Makrophagen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE28477T1 true ATE28477T1 (de) | 1987-08-15 |
Family
ID=9300201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT85400080T ATE28477T1 (de) | 1984-01-17 | 1985-01-17 | Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0149581B1 (de) |
| JP (1) | JPS60161926A (de) |
| AT (1) | ATE28477T1 (de) |
| DE (1) | DE3560366D1 (de) |
| FR (1) | FR2558165B1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0153871A3 (de) * | 1984-03-01 | 1987-07-01 | Centocor, Inc. | Steigerung der Antigenimmunogenität mittels Antikörper |
| US4879225A (en) * | 1986-06-20 | 1989-11-07 | Neorx Corporation | Enhanced production of antibodies utilizing insolubilized immune complexes |
| CN1034986C (zh) * | 1993-04-22 | 1997-05-28 | 上海医科大学 | 一种新型免疫原性复合物制剂及制备方法 |
| JP3669758B2 (ja) * | 1995-06-15 | 2005-07-13 | ユニ・チャーム株式会社 | 蓋装置 |
| EP3323424A1 (de) | 2016-11-17 | 2018-05-23 | Cyanimal IP | Cyaa-polypeptide als immunomodulatorenverstärker |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1138436A (en) * | 1978-02-24 | 1982-12-28 | Gerhard Baschang | Process for the manufacture of novel antigens |
| FR2522967B1 (fr) * | 1982-03-15 | 1986-03-07 | Anvar | Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant |
-
1984
- 1984-01-17 FR FR8400676A patent/FR2558165B1/fr not_active Expired
-
1985
- 1985-01-16 JP JP60005632A patent/JPS60161926A/ja active Pending
- 1985-01-17 DE DE8585400080T patent/DE3560366D1/de not_active Expired
- 1985-01-17 AT AT85400080T patent/ATE28477T1/de active
- 1985-01-17 EP EP85400080A patent/EP0149581B1/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DE3560366D1 (en) | 1987-08-27 |
| EP0149581B1 (de) | 1987-07-22 |
| JPS60161926A (ja) | 1985-08-23 |
| FR2558165A1 (fr) | 1985-07-19 |
| EP0149581A3 (en) | 1985-08-28 |
| FR2558165B1 (fr) | 1986-07-04 |
| EP0149581A2 (de) | 1985-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3580420D1 (de) | 1,10-phenanthrolin-2,9-dicarbonsaeure-derivate und deren verwendung fuer fluoreszens-immunoassay. | |
| HUT59322A (en) | Ultrasonic contrast materials, process for producing them and for using them as diagnostic and therepeutic agents | |
| DE69022760D1 (de) | Allgemeinverfahren für die Bestätigung von Krebs. | |
| DE3764770D1 (de) | Anordnung fuer die dosierung von kraftstoff sowie dosiervorrichtung dafuer. | |
| IT8621232A0 (it) | Copolimeri silitati dell'isobutilene reticolabili in condizioni ambientali eprocedimento per la loro preparazione. | |
| IT8719773A0 (it) | Anello d'attrito per frizioni oppure per freni, procedimento e dispositivo per la realizzazione dell'anello d'attrito stesso. | |
| DE3583998D1 (de) | Polyimidvorlaeufer-harzzusammensetzung und halbleiterkomponente, die dieselbe verwendet. | |
| IT7883451A0 (it) | Fune d' acciaio-alluminio particolarmente idonea per la conduzione di elettricita' eprocedimento per la produzione ditale fune. | |
| DE3863195D1 (de) | Feste base, verfahren zu deren herstellung und ihre anwendung fuer die herstellung von olefinen mit innerer doppelbindung. | |
| DE3579676D1 (de) | Zusammengesetzte harzteilchen, ihre herstellung und harzmasse fuer ueberzugszwecke die diese enthaelt. | |
| ATE28477T1 (de) | Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen. | |
| AT359763B (de) | Vorrichtung, insbesondere fuer die bearbeitung von rasenflaechen u.dgl. | |
| IT8019874A0 (it) | Nuovi portamonete, borse e simili, e loro procedimento di fabbricazione. | |
| IT8023483A0 (it) | Procedimento per la produzione per via silicotermica, in siviera, di leghe a base di manganese e di silicio. | |
| JPS57122054A (en) | Tridecapeptide and manufacture | |
| DE3670632D1 (de) | Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper. | |
| IT1082078B (it) | Procedimento per la fabbricazione di tamponi mestruali e tamponi cosi' costituiti | |
| DE3856007D1 (de) | Lichtfilter für die mikroelektronik | |
| EP0374946A3 (de) | Verfahren zum Nachweis von kohlenhydrathaltigen Verbindungen | |
| ATE58295T1 (de) | Zubereitung mit gehalt an einem antiprogestomimetischen und einem uterotonischen stoff. | |
| BR7704900A (pt) | Processo para a preparacao de o-etil-s-n-propil-o-2,2,2-trihalogeno-etilfos-fotiolatos(ou tionotiolatos)e composicao inseticida,acaricida ou nematocida a base destes | |
| IT1115507B (it) | Specchio convergente,in particolare per "centrali solari",procedimento per la sua fabbricazione e dispositivo per l'attuazione del detto procedimento | |
| EP0485476A4 (en) | Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof | |
| EP0394644A3 (de) | Halogenbenzolderivate | |
| ATE83930T1 (de) | Antikoerper enthaltende stabilisierte waesserige zusammensetzung. |